Dr. Kimberly Beck Suri, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Ct, Kaiser Permanente Springfield Medical Center, Springfield, VA 22150 Phone: 703-922-1000 |
Dr. Sonya L Krolik, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Ct Fl 6, Springfield, VA 22150 Phone: 703-922-1000 Fax: 703-922-1191 |
Dr. Julia H Sone, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Ct, Springfield Medical Center, Springfield, VA 22150 Phone: 703-922-1528 Fax: 703-922-1199 |
Dr. Alexandra E Booth, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Court, Springfield, VA 22150 Phone: 703-922-1528 Fax: 703-922-1199 |
Virginia P Madey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Ct, Springfield, VA 22150 Phone: 703-359-7878 |
Dr. Waylan Ables Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 6501 Loisdale Ct, Kaiser Permanente Springfield Medical Center, Springfield, VA 22150 Phone: 703-922-1000 |
Kelly Michelle Meehan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Ct, Springfield, VA 22150 Phone: 703-922-1000 |
News Archive
A new approach to repairing peripheral nerves marries the regenerating power of gingiva-derived mesenchymal stem cells with a biological scaffold to enable the functional recovery of nerves following a facial injury, according to a study by a cross-disciplinary team from the University of Pennsylvania School of Dental Medicine and Perelman School of Medicine.
Taro Pharmaceutical Industries Ltd. announced that it has begun Phase I clinical trials in Canada with T2007, the second in the Company's class of proprietary non-sedating barbiturate compounds to be approved for studies in humans.
Breast cancer screening leads three women to receive unnecessary treatment for every woman whose life is saved, an independent UK panel has concluded.
Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
› Verified 8 days ago